Metformin acts as a dual glucose regulator in mouse brain
Frontiers in Pharmacology · 20.04.2023 · 14
DOI: 10.3389/fphar.2023.1108660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.04.2023. Verfasst von Bo-Yeong Jin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Korea University College of Medicine, Seoul, Republic of Korea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea University Medicine.
Abstract (Originalsprache)
Aims
Metformin improves glucose regulation through various mechanisms in the periphery. Our previous study revealed that oral intake of metformin activates several brain regions, including the hypothalamus, and directly activates hypothalamic S6 kinase in mice. In this study, we aimed to identify the direct effects of metformin on glucose regulation in the brain. Materials and methods: We investigated the role of metformin in peripheral glucose regulation by directly administering metformin intracerebroventricularly in mice. The effect of centrally administered metformin (central metformin) on peripheral glucose regulation was evaluated by oral or intraperitoneal glucose, insulin, and pyruvate tolerance tests. Hepatic gluconeogenesis and gastric emptying were assessed to elucidate the underlying mechanisms. Liver-specific and systemic sympathetic denervation were performed.
Results
Central metformin improved the glycemic response to oral glucose load in mice compared to that in the control group, and worsened the response to intraperitoneal glucose load, indicating its dual role in peripheral glucose regulation. It lowered the ability of insulin to decrease serum glucose levels and worsened the glycemic response to pyruvate load relative to the control group. Furthermore, it increased the expression of hepatic G6pc and decreased the phosphorylation of STAT3, suggesting that central metformin increased hepatic glucose production. The effect was mediated by sympathetic nervous system activation. In contrast, it induced a significant delay in gastric emptying in mice, suggesting its potent role in suppressing intestinal glucose absorption.
Conclusion
Central metformin improves glucose tolerance by delaying gastric emptying through the brain-gut axis, but at the same time worsens it by increasing hepatic glucose production via the brain-liver axis. However, with its ordinary intake, central metformin may effectively enhance its glucose-lowering effect through the brain-gut axis, which could surpass its effect on glucose regulation via the brain-liver axis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Korea University College of Medicine, Seoul, Republic of Korea.
- Graduate School of Medicine, Korea University, Seoul, Republic of Korea.
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Korea University Medicine
Zitieren
APA
Jin, B. Y., Kim, H. J., Oh, M. J., Ha, N. H., Jeong, Y. T., Choi, S. H., Lee, J. S., Kim, N. H., & Kim, D. H. (2023). Metformin acts as a dual glucose regulator in mouse brain. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1108660
Vancouver
Jin BY, Kim HJ, Oh MJ, Ha NH, Jeong YT, Choi SH, et al. Metformin acts as a dual glucose regulator in mouse brain. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1108660
BibTeX
@article{Jin2023,
author = {Jin, Bo-Yeong and Kim, Hyun-Ju and Oh, Mi-Jeong and Ha, Na-Hee and Jeong, Yong Taek and Choi, Sang-Hyun and Lee, Jun-Seok and Kim, Nam Hoon and Kim, Dong-Hoon},
title = {Metformin acts as a dual glucose regulator in mouse brain},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1108660}
}
EUVIMED